Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT IX in connection with the acquisition of Cerba Healthcare
Mandate

Vinge advises EQT IX in connection with the acquisition of Cerba Healthcare

September 14, 2021 EU, Competition and Regulatory

Vinge has advised EQT IX on the merger control aspects of EQT IX’s acquisition of Cerba Healthcare, a provider of routine, specialty and research medical lab testing in EMEA.

The acquisition was notified to, inter alia, the European Commission. Vinge’s team consisted primarily of Emma Johansson and Johan Wahlbom.

Related

Vinge advises Sertion in connection with the acquisition of Kiefer System Group

 Vinge has advised Sertion AB (“Sertion”) in connection with the acquisition of Kiefer System Group.
October 10, 2025

Vinge advises Main Capital and Aritma in connection with the acquisition of Programekonomi

 Vinge has advised Aritma International AS (“Aritma”), a Norwegian bank-connectivity and financial automation software provider, in connection with the acquisition of Programekonomi Svenska Aktiebolag.
October 09, 2025

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025